Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-02-18

Clinical Trial Update: Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA

View source ↗

Summary

An observational study evaluating the management of ulcerative colitis with oral mesalamine (5-aminosalicylic acid) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

Sponsor: Kyorin Pharmaceutical Co.,Ltd | Conditions: Ulcerative Colitis | Status: COMPLETED